Paper · 6333383
Fine-specificity of the immune response to oxazolones. IV. Furyloxazolone-specific cytolytic T lymphocytes (unlike antibodies) are not heteroclitic.
Matoso-Ferreira A. Immunology, 1984. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fine-specificity of the immune response to oxazolones. IV. Furyloxazolone-specific cytolytic T lymphocytes (unlike antibodies) are not heteroclitic. Papers, record 6333383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6333383
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fine-specificity of the immune response to oxazolones. IV. Furyloxazolone-specific cytolytic T lymphocytes (unlike antibodies) are not heteroclitic.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Oxazoles | Major topic |
| Oxazolone | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Animals | |
| Antibody Affinity | |
| Cytotoxicity, Immunologic | |
| Female | |
| Haptens | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred CBA |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,838,759 | Single lymph node cells producing heteroclitic bacteriophage antibody. | J Immunol | 1965 | https://conductscience.org/library/papers/5838759 | PubMed |
| 2 | 4,423,747 | Fluorescent labeling of proteins and a plasma membrane using cycloheptaamylose-dansyl chloride complex. | Anal Biochem | 1974 | https://conductscience.org/library/papers/4423747 | PubMed |
| 3 | 4,139,230 | Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. | J Exp Med | 1974 | https://conductscience.org/library/papers/4139230 | PubMed |
| 4 | 135,687 | Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. | Eur J Immunol | 1976 | https://conductscience.org/library/papers/135687 | PubMed |
| 5 | 62,013 | Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds. | J Exp Med | 1976 | https://conductscience.org/library/papers/62013 | PubMed |
| 6 | 87,325 | Fine specificity of cytotoxic T lymphocytes: C57BL effector cells induced by autologous cells modified with hapten (4-hydroxy-3-nitro-phenyl)acetyl (NIP) are not heteroclitic. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/87325 | PubMed |
| 7 | 109,567 | Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. I. Genetic control of delayed-type hypersensitivity by VH and I-A-region genes. | J Exp Med | 1979 | https://conductscience.org/library/papers/109567 | PubMed |
| 8 | 90,089 | A hapten-specific Ir gene. | J Immunol | 1979 | https://conductscience.org/library/papers/90089 | PubMed |
| 9 | 6,967,910 | Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. | J Immunol | 1980 | https://conductscience.org/library/papers/6967910 | PubMed |
| 10 | 6,969,772 | Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VI. Evidence for different T cell receptors in cells that mediate H-21-restricted and H-2D-restricted cutaneous sensitivity responses. | J Exp Med | 1980 | https://conductscience.org/library/papers/6969772 | PubMed |
1 to 10 of 16
See all 16 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6333383
GET https://conductscience.org/api/papers/v1/6333383/authors